Question 1

What is ApoB and why does it matter more than LDL?

Accepted Answer

ApoB counts every atherogenic lipoprotein particle that can penetrate an arterial wall, LDL, VLDL, IDL, and Lp(a), while LDL-cholesterol measures only the cholesterol content within LDL particles; ApoB predicts cardiovascular events more accurately than LDL-C because particle count (not cholesterol concentration) determines how many particles can penetrate arterial walls, and in men with metabolic syndrome or high triglycerides, LDL-C can be normal while ApoB is dangerously elevated (discordance

Question 2

What is Lp(a) and why hasn't my doctor tested it?

Accepted Answer

Lp(a) (lipoprotein(a)) is an LDL-like particle with an additional apo(a) protein attached, is genetically determined (not diet-responsive), and is elevated in approximately 20% of the population, at levels above 50 mg/dL, it independently doubles to triples early cardiovascular event risk through both atherogenic and thrombogenic mechanisms, making it the most common undiagnosed cardiovascular risk factor in otherwise healthy men with normal LDL, and it should be measured once in every adult's l

Question 3

ApoB vs. LDL — which one should I be tracking?

Accepted Answer

LDL cholesterol measures the total cholesterol content of LDL particles, while ApoB counts the total number of atherogenic lipoprotein particles (LDL, VLDL, IDL, and Lp(a)), ApoB predicts cardiovascular events more accurately than LDL-C because particle count, not cholesterol concentration, determines how many particles can penetrate arterial walls; the Emerging Risk Factors Collaboration analysis of 302,430 individuals found ApoB superior to LDL-C in almost all cardiovascular risk prediction co

Question 4

What is a CAC (calcium score) CT scan and should I get one?

Accepted Answer

A coronary artery calcium (CAC) score CT is a non-invasive low-radiation scan (equivalent to about 20 chest X-rays) that quantifies calcified plaque in the coronary arteries, producing a score (Agatston units) that directly measures the burden of atherosclerotic disease already present, with a score of 0 indicating extremely low cardiovascular event risk for the next 10–15 years, and a score above 100 indicating substantial plaque burden warranting aggressive cardiovascular risk management (Agat

Question 5

What is the real story on HDL — is high HDL actually protective?

Accepted Answer

HDL (high-density lipoprotein) cholesterol has long been promoted as "good cholesterol" because high HDL is associated with lower cardiovascular risk in observational studies, but Mendelian randomization studies (which test genetic variants that raise HDL without changing other factors) have found that genetically elevated HDL does not reduce cardiovascular events, suggesting HDL-C is a marker of cardiovascular health rather than a cause of it, and raising HDL pharmacologically (niacin, CETP inh

Question 6

Are statins safe — the honest long-term assessment?

Accepted Answer

Statins (HMG-CoA reductase inhibitors) are among the most extensively studied medications in history, with over 300,000 patients in RCTs, they reduce major cardiovascular events by approximately 25–35% relative risk reduction per 38–39 mg/dL LDL-C reduction, with an excellent safety profile in large trials, though real-world use reveals a 5–10% rate of muscle symptoms (myalgia), a small but real increase in new-onset type 2 diabetes risk (approximately 1 excess case per 250 patients treated for

Question 7

What is oxidized LDL and how is it different from regular LDL?

Accepted Answer

Oxidized LDL (ox-LDL) refers to LDL particles that have undergone lipid peroxidation, reacting with reactive oxygen species to form modified particles that are taken up by arterial wall macrophages (scavenger receptors are not regulated by cellular cholesterol feedback, so macrophages engorge with lipid and become "foam cells"), driving the initial stages of atherosclerotic plaque formation in a way that native unoxidized LDL does not directly (Witztum & Steinberg, J Clin Invest, 1991). Oxidized

Question 8

My LDL is "normal" but my cardiologist is recommending a statin. Why?

Accepted Answer

A cardiologist recommending statin therapy to a man with LDL-C of 100–130 mg/dL is likely considering: (1) ApoB above 80–90 mg/dL suggesting particle-count risk beyond what LDL-C captures; (2) Lp(a) above 50 mg/dL adding independent cardiovascular risk; (3) elevated hs-CRP above 2 mg/L combined with LDL below 130 mg/dL (the JUPITER trial indication, reduced cardiovascular events with statin in this exact population); (4) CAC score above 100, indicating established coronary plaque requiring risk

Question 9

What is PCSK9 — and is this the next big thing in cholesterol management?

Accepted Answer

PCSK9 (proprotein convertase subtilisin/kexin type 9) is a protein that degrades LDL receptors on the liver surface, reducing the liver's capacity to clear LDL particles, PCSK9 inhibitors (evolocumab/Repatha, alirocumab/Praluent) are injectable antibodies that block PCSK9, increasing LDL receptor recycling and dramatically reducing ApoB and LDL-C (by 50–60% beyond statin therapy), with the FOURIER and ODYSSEY trials showing significant cardiovascular event reduction in high-risk patients who are

Question 10

What is familial hypercholesterolemia and should I worry about my family history?

Accepted Answer

Familial hypercholesterolemia (FH) is an autosomal dominant genetic condition causing severely elevated LDL-C (typically above 190 mg/dL untreated) from birth due to mutations in the LDL receptor, APOB, or PCSK9 genes, affecting approximately 1 in 200–250 people, and requires aggressive, lifelong lipid-lowering therapy starting in childhood; it is severely underdiagnosed, with an estimated 90% of FH patients undiagnosed in the US (Nordestgaard et al., Eur Heart J, 2013). The clinical red flags f

Question 11

Does diet really change cholesterol — by how much?

Accepted Answer

Dietary saturated fat and trans fat reduce LDL receptor expression and raise LDL-C, replacing 5% of dietary energy from saturated fat with unsaturated fat reduces LDL-C by approximately 10–14 mg/dL, while dietary cholesterol (eggs, shellfish) has a smaller and more variable effect on plasma LDL-C, and the most powerful dietary LDL-reducing approach for most men is a Mediterranean or plant-enriched eating pattern combined with saturated fat reduction, which can reduce LDL-C by 15–30 mg/dL from ba

Question 12

What are triglycerides and when should I be worried about mine?

Accepted Answer

Triglycerides are blood lipids (fat molecules) that reflect recent carbohydrate and fat intake, alcohol consumption, and insulin resistance, normal fasting triglycerides are below 150 mg/dL, borderline high is 150–199 mg/dL, high is 200–499 mg/dL (associated with increased cardiovascular risk), and very high above 500 mg/dL (associated with pancreatitis risk), elevated fasting triglycerides are often the first lipid abnormality in men developing insulin resistance and metabolic syndrome (Miller

Question 13

What is the "remnant cholesterol" concept and why is it becoming more important?

Accepted Answer

Remnant cholesterol (RC) refers to the cholesterol carried in triglyceride-rich lipoprotein remnants (VLDL remnants, IDL) after triglyceride removal, it is calculated as total cholesterol minus LDL-C minus HDL-C, and a 2020 Mendelian randomization study in 106,000 individuals found that elevated remnant cholesterol caused coronary artery disease independently of LDL-C, establishing it as a causal cardiovascular risk factor rather than merely a marker (Varbo et al., JACC, 2020). Remnant cholester

Question 14

What happens to lipids during a stressful period — like a major crisis?

Accepted Answer

Acute psychological stress and physiological stress (illness, surgery, major emotional events) transiently elevate LDL-C, total cholesterol, and fibrinogen, through stress-induced lipolysis releasing free fatty acids that drive hepatic VLDL production, cortisol-mediated LDL receptor downregulation, and hemoconcentration, making a single lipid panel drawn during a period of acute stress unrepresentative of the individual's true metabolic lipid state (Muldoon et al., Arch Intern Med, 1992). The cl

Question 15

Is the keto diet good for cholesterol?

Accepted Answer

Ketogenic diets have variable effects on lipids depending on the fat composition: in many men, keto reduces triglycerides substantially (30–50%) and raises HDL-C (10–20%), but can raise LDL-C significantly in approximately 25–30% of men, and ApoB can rise even in men whose LDL-C does not change prominently, due to increased VLDL and small-dense LDL production from the high saturated fat load in many keto implementations (Volek et al., Prog Lipid Res, 2008). The "keto improves cholesterol" claim

Question 16

What does it mean to have a "heart-healthy" cholesterol — the actual numbers?

Accepted Answer

A "heart-healthy" lipid profile for a middle-risk man over 40 with no prior cardiovascular events: ApoB below 80 mg/dL, LDL-C below 100 mg/dL, non-HDL-C below 130 mg/dL, triglycerides below 150 mg/dL, HDL-C above 40 mg/dL, Lp(a) below 50 mg/dL, and for high-risk men (prior cardiovascular event, diabetes, familial hypercholesterolemia): ApoB below 65 mg/dL, LDL-C below 70 mg/dL, and Lp(a) management depending on absolute level (Grundy et al., JACC, 2019). The "heart-healthy" label applied to food

Question 17

What is the first lab I should order if I have a family history of heart attacks?

Accepted Answer

If you have a first-degree relative (parent, sibling) who had a heart attack before age 55 (men) or 65 (women), the most clinically informative initial panel includes: (1) fasting lipid panel with ApoB; (2) Lp(a), this is the most common explanation for premature familial coronary disease with normal LDL-C; (3) hs-CRP; (4) fasting glucose with insulin; (5) blood pressure measurement; and (6) a discussion with a cardiologist about whether a coronary artery calcium (CAC) score CT is indicated (Gru

Question 18

What is lipoprotein(a) genetic inheritance — if my father has high Lp(a), what is my risk?

Accepted Answer

Lp(a) levels are 70–90% heritable, meaning your Lp(a) level is primarily genetically determined and is largely unaffected by diet, exercise, or standard lipid-lowering medications (statins modestly increase Lp(a) by approximately 10–15%), and with autosomal codominant inheritance, a child of a parent with elevated Lp(a) has approximately 50% probability of inheriting elevated Lp(a) (Kronenberg, Nat Rev Drug Discov, 2024). If your father or mother has Lp(a) above 50 mg/dL and a history of prematu

Question 19

What is remnant lipoprotein testing — is it worth getting?

Accepted Answer

Remnant lipoprotein cholesterol (measured directly as IDL-C + chylomicron remnants, or calculated as total cholesterol minus LDL-C minus HDL-C) is available on some advanced lipid panels (LabCorp NMR LipoProfile, Quest Cardio IQ) and provides additional cardiovascular risk information beyond the standard lipid panel, particularly valuable in men with elevated triglycerides where the non-LDL atherogenic particle burden is incompletely captured by standard LDL-C measurement (Varbo et al., JACC, 20

Question 20

How does alcohol affect my lipid panel?

Accepted Answer

Moderate alcohol consumption (1–2 drinks/day) raises HDL-C by approximately 4–5 mg/dL through increased apolipoprotein A-I production, this is the mechanism behind the observational association between moderate drinking and "better" lipid profiles, but it also raises triglycerides, has no beneficial effect on ApoB or LDL-C, and the apparent cardiovascular benefit from HDL-raising is not supported by Mendelian randomization data showing no causal cardiovascular protection from genetically elevate

Question 21

What is the "ApoB under 80" target — and how hard is it to achieve?

Accepted Answer

An ApoB below 80 mg/dL is the target associated with the lowest quartile of cardiovascular risk in most large cohort studies, achievable in average-risk men without pharmacological therapy through: LDL-C-reducing dietary changes (saturated fat reduction, soluble fiber increase), visceral fat loss of 5–10% body weight, and right insulin sensitivity, combined these can reduce ApoB by 15–25 mg/dL from an elevated baseline in 3–6 months; men starting above 100 mg/dL typically require statin therapy

Question 22

What does "non-HDL cholesterol" mean and when is it useful?

Accepted Answer

Non-HDL cholesterol (total cholesterol minus HDL-C) is an easily calculated metric that includes LDL-C plus VLDL-C plus IDL-C (all atherogenic particles), it is a better predictor of cardiovascular events than LDL-C alone because it includes the triglyceride-rich lipoprotein fraction, and it correlates more closely with ApoB than LDL-C does, making it the most accessible ApoB proxy available from a standard lipid panel without additional cost (Boekholdt et al., JAMA, 2012). Non-HDL cholesterol i

ApoB / Lp(a) / Lipids